Nano biotherapeutics - tlooto, The Most Powerful AcademicGPT

Nano biotherapeutics represent a dynamic convergence of nanotechnology and biotechnology to develop therapeutic agents at the nanometer scale (1–100 nm), with the goal of improving drug delivery, targeting, and clinical efficacy across diverse medical fields. Recent advances in this domain are propelling the emergence of novel modalities for the treatment, diagnosis, and prevention of diseases ranging from cancer to inflammatory and infectious conditions. --- Core Components and Platforms Nanocarriers: A wide range of nanocarriers serve as the foundation of nano biotherapeutics, with each offering unique physicochemical and biological advantages: - Lipid-based nanoparticles (e.g., liposomes, solid lipid nanoparticles): Long utilized for their biocompatibility, these constructs can encapsulate both hydrophilic and hydrophobic agents, improving drug solubility, half-life, and reducing systemic toxicity. New generations of lipid-based nanoparticles (e.g., hybrid lipid nanoparticles) are e